Skip to main content

Table 3 Univariate Analysis for recurrence-free survival (RFS) and overall survival (OS)

From: Neutrophil-lymphocyte ratio complements volumetric staging as prognostic factor in patients treated with definitive radiotherapy for oropharyngeal cancer

  RFS OS
  HR Conf. int. p-value HR Conf. int. p-value
Age 1.001 0.9729–1.03 0.942 1.018 0.9932–1.043 0.157
Sex 0.7161 0.3755–1.366 0.308 0.755 0.4312–1.321 0.323
Normal ECOG 0.3812 0.213–0.6823 0.002 0.333 0.2009–0.5518 < 0.001
UICC stage 1.14 0.6254–2.079 0.668 1.163 0.6781–1.996 0.582
No smoking history 0.2293 0.05573–0.9431 0.026 0.314 0.1142–0.8635 0.018
Chemotherapy
(full dose)
0.5653 0.3158–1.012 0.052 0.555 0.335–0.9195 0.021
Tumor volume 1.015 1.008–1.021 < 0.001 1.011 1.005–1.017 < 0.001
NLR 4.059 2.315–7.117 < 0.001 2.311 1.438–3.714 < 0.001